These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5564733)

  • 61. [Comparative assessment of the five-year results of surgical, combined, radiation and chemoradiotherapy in laryngeal cancer (T3N0M0)].
    Tkachëv SI; Matiakin EG; Liubaev VL; Boĭkov VP; Alieva SB; Aliev BM; Kondrat'eva AP; Aketova TA; Pirogova NA; Loginova IN
    Vopr Onkol; 2006; 52(4):404-7. PubMed ID: 17024811
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Combined therapy of laryngeal cancer].
    Tachibana M; Kawano K; Kitamura T; Kaneko T; Shimada F
    Nihon Jibiinkoka Gakkai Kaiho; 1971 Feb; 74(2):414-5. PubMed ID: 5106641
    [No Abstract]   [Full Text] [Related]  

  • 63. [Laryngeal Preservation with Induction Chemotherapy. Experience of two GETTEC Centers, Between 1985 and 1995].
    Janot F; Rhein B; Koka VN; Wibault P; Domenge C; Bessede JP; Marandas P; Schwaab G; Luboinski B
    Ann Otolaryngol Chir Cervicofac; 2002 Feb; 119(1):12-20. PubMed ID: 11965102
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical and pathological data of 10 malignant pheochromocytomas: long-term follow up in a single institute.
    Huang KH; Chung SD; Chen SC; Chueh SC; Pu YS; Lai MK; Lin WC
    Int J Urol; 2007 Mar; 14(3):181-5. PubMed ID: 17430251
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Treatment of 125 sinonasal tumors: prognostic factors, outcome, and follow-up.
    Blanch JL; Ruiz AM; Alos L; Traserra-Coderch J; Bernal-Sprekelsen M
    Otolaryngol Head Neck Surg; 2004 Dec; 131(6):973-6. PubMed ID: 15577800
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Metastasis of adenocarcinoma of the ovary to the subglottis. A laryngologic rarity].
    Oeken J; Meister E; Behrendt W
    HNO; 1996 Jan; 44(1):27-31. PubMed ID: 8819726
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Follow-up of the immunological condition of patients with malignant otolaryngolgic tumors using the tuberculin test].
    Pihrt J; Nedvĕdová
    Cesk Otolaryngol; 1976 Apr; 25(2):80-3. PubMed ID: 1277367
    [No Abstract]   [Full Text] [Related]  

  • 68. Radiotherapy for squamous cell carcinoma of the nasal cavity.
    Sakashita M; Nakajima T; Tsumura M; Hosono M; Nishita T; Onoyama Y
    Radiat Med; 1993; 11(3):91-4. PubMed ID: 8372243
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Long-term results of treatment of cancer of the larynx by radiotherapy. Classification and statistical study bearing on 470 cases with a follow-up of 5 years].
    Popovitch V; Podvinec S; Nesitch D; Lazarevitch D
    J Radiol Electrol Med Nucl; 1967; 48(3):183-6. PubMed ID: 6061431
    [No Abstract]   [Full Text] [Related]  

  • 70. Squamous cell carcinoma of the external auditory canal: long-term clinical outcomes using surgery and external-beam radiotherapy.
    Prabhu R; Hinerman RW; Indelicato DJ; Morris CG; Werning JW; Vaysberg M; Amdur RJ; Kirwan J; Mendenhall WM
    Am J Clin Oncol; 2009 Aug; 32(4):401-4. PubMed ID: 19398900
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
    Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
    Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Triple-combined therapy of malignant cancer of the head and neck--on laryngeal cancer].
    Hitoto I
    J Dent Educ; 1969 Dec; 33(4):577-80. PubMed ID: 5259887
    [No Abstract]   [Full Text] [Related]  

  • 73. Options for preserving the larynx in patients with advanced laryngeal and hypopharyngeal cancer.
    Wolf GT
    Ear Nose Throat J; 2001 Dec; 80(12):897-901. PubMed ID: 11775526
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Interstitial brachytherapy of peri-orificial skin carcinomas on the face].
    Rio E; Bardet E; Ferron C; Peuvrel P; Supiot S; Campion L; Beauvillain De Montreuil C; Mahe MA; Dreno B
    Cancer Radiother; 2006 May; 10(3):101-6. PubMed ID: 16529964
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Role of induction chemotherapy in advanced carcinoma of the larynx].
    Yu SG
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1993; 28(1):43-4, 60. PubMed ID: 7688976
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Prognostic factors in childhood sarcomas of neuroectodermal histogenesis].
    Budarin MA
    Vopr Onkol; 2002; 48(3):335-9. PubMed ID: 12455358
    [No Abstract]   [Full Text] [Related]  

  • 77. [Comparative results of treatment of laryngeal neoplasm. (An evaluation of 5 years of neoplasm registration in the German Democratic Republic) I].
    Bockmühl F; Mros B; Herold HJ
    Z Laryngol Rhinol Otol; 1968 Aug; 47(8):627-39. PubMed ID: 5726722
    [No Abstract]   [Full Text] [Related]  

  • 78. Quality of life after treatment for advanced laryngeal and hypopharyngeal cancer.
    Major MS; Bumpous JM; Flynn MB; Schill K
    Laryngoscope; 2001 Aug; 111(8):1379-82. PubMed ID: 11568572
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Single modality and multimodality treatment of nasal and paranasal sinuses cancer: a single institution experience of 229 patients.
    Guntinas-Lichius O; Kreppel MP; Stuetzer H; Semrau R; Eckel HE; Mueller RP
    Eur J Surg Oncol; 2007 Mar; 33(2):222-8. PubMed ID: 17127030
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Laryngeal T4 carcinomas. The possibility of conservative treatment. Long-term oncological and functional results].
    De Campora E; Radici M; Bicciolo G
    Acta Otorhinolaryngol Ital; 1995 Feb; 15(1):28-39. PubMed ID: 7597900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.